Who’s Winning the Global Showdown?
The U.S. stock market, led by indices like the S&P 500 and Nasdaq, has long been the benchmark for global investment. Its appeal lies in strong corporate profitability, technological dominance, and high liquidity, drawing in investors worldwide. Despite challenges like Fed rate hikes and inflation concerns, U.S. stocks have shown resilience, driven by innovation in
TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications
EDINBURGH, Scotland, Aug. 28, 2024 /PRNewswire/ — TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has received a patent grant from European Patent Office (EPO) covering the use of modified gamma delta